These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 29946183)

  • 1. Genomic profiling of metaplastic breast carcinomas reveals genetic heterogeneity and relationship to ductal carcinoma.
    Krings G; Chen YY
    Mod Pathol; 2018 Nov; 31(11):1661-1674. PubMed ID: 29946183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metaplastic breast carcinomas display genomic and transcriptomic heterogeneity [corrected].
    Weigelt B; Ng CK; Shen R; Popova T; Schizas M; Natrajan R; Mariani O; Stern MH; Norton L; Vincent-Salomon A; Reis-Filho JS
    Mod Pathol; 2015 Mar; 28(3):340-51. PubMed ID: 25412848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Landscape of Somatic Genetic Alterations in Metaplastic Breast Carcinomas.
    Ng CKY; Piscuoglio S; Geyer FC; Burke KA; Pareja F; Eberle CA; Lim RS; Natrajan R; Riaz N; Mariani O; Norton L; Vincent-Salomon A; Wen YH; Weigelt B; Reis-Filho JS
    Clin Cancer Res; 2017 Jul; 23(14):3859-3870. PubMed ID: 28153863
    [No Abstract]   [Full Text] [Related]  

  • 4. Whole-Exome Sequencing of Metaplastic Breast Carcinoma Indicates Monoclonality with Associated Ductal Carcinoma Component.
    Avigdor BE; Beierl K; Gocke CD; Zabransky DJ; Cravero K; Kyker-Snowman K; Button B; Chu D; Croessmann S; Cochran RL; Connolly RM; Park BH; Wheelan SJ; Cimino-Mathews A
    Clin Cancer Res; 2017 Aug; 23(16):4875-4884. PubMed ID: 28424200
    [No Abstract]   [Full Text] [Related]  

  • 5. Triple-Negative Apocrine Carcinomas: Toward a Unified Group With Shared Molecular Features and Clinical Behavior.
    Schwartz CJ; Ruiz J; Bean GR; Sirohi D; Joseph NM; Hosfield EM; Jacobs TW; Mukhtar RA; Chen YY; Krings G
    Mod Pathol; 2023 May; 36(5):100125. PubMed ID: 36870308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique clinicopathological features of metaplastic breast carcinoma compared with invasive ductal carcinoma and poor prognostic indicators.
    Song Y; Liu X; Zhang G; Song H; Ren Y; He X; Wang Y; Zhang J; Zhang Y; Sun S; Liang X; Sun Q; Pang D
    World J Surg Oncol; 2013 Jun; 11():129. PubMed ID: 23738706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathway activity profiling of growth factor receptor network and stemness pathways differentiates metaplastic breast cancer histological subtypes.
    McQuerry JA; Jenkins DF; Yost SE; Zhang Y; Schmolze D; Johnson WE; Yuan Y; Bild AH
    BMC Cancer; 2019 Sep; 19(1):881. PubMed ID: 31488082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative proteomic landscape of metaplastic breast carcinoma pathological subtypes and their relationship to triple-negative tumors.
    Djomehri SI; Gonzalez ME; da Veiga Leprevost F; Tekula SR; Chang HY; White MJ; Cimino-Mathews A; Burman B; Basrur V; Argani P; Nesvizhskii AI; Kleer CG
    Nat Commun; 2020 Apr; 11(1):1723. PubMed ID: 32265444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix-producing metaplastic breast carcinoma - a rare tumor with heterologous elements.
    Shruti S; Siraj F
    Ger Med Sci; 2017; 15():Doc17. PubMed ID: 29255401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metaplastic carcinoma of the breast.
    Okada N; Hasebe T; Iwasaki M; Tamura N; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Kanai Y; Kinoshita T
    Hum Pathol; 2010 Jul; 41(7):960-70. PubMed ID: 20236684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive apocrine carcinoma of the breast: clinicopathologic features and comprehensive genomic profiling of 18 pure triple-negative apocrine carcinomas.
    Sun X; Zuo K; Yao Q; Zhou S; Shui R; Xu X; Bi R; Yu B; Cheng Y; Tu X; Lu H; Yang W
    Mod Pathol; 2020 Dec; 33(12):2473-2482. PubMed ID: 32504034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metaplastic breast carcinoma: pathology and clinical outcome.
    Bellino R; Arisio R; D'Addato F; Attini R; Durando A; Danese S; Bertone E; Grio R; Massobrio M
    Anticancer Res; 2003; 23(1B):669-73. PubMed ID: 12680165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatial molecular profiling of mixed invasive ductal and lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutations.
    Shah OS; Nasrazadani A; Foldi J; Atkinson JM; Kleer CG; McAuliffe PF; Johnston TJ; Stallaert W; da Silva EM; Selenica P; Dopeso H; Pareja F; Mandelker D; Weigelt B; Reis-Filho JS; Bhargava R; Lucas PC; Lee AV; Oesterreich S
    Proc Natl Acad Sci U S A; 2024 Jul; 121(31):e2322068121. PubMed ID: 39042692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metaplastic breast cancer with a unique presentation and complete response to chemotherapy: a case report.
    Nahhat F; Doyya M; Zabad K; Ksiri H
    BMC Womens Health; 2024 May; 24(1):285. PubMed ID: 38734591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metaplastic Carcinoma of the Breast Is More Aggressive Than Triple-negative Breast Cancer: A Study From a Single Institution and Review of Literature.
    El Zein D; Hughes M; Kumar S; Peng X; Oyasiji T; Jabbour H; Khoury T
    Clin Breast Cancer; 2017 Aug; 17(5):382-391. PubMed ID: 28529029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mixed subtype has a worse prognosis than other histological subtypes: a retrospective analysis of 217 patients with metaplastic breast cancer.
    Hu J; Lang R; Zhao W; Jia Y; Tong Z; Shi Y
    Breast Cancer Res Treat; 2023 Jul; 200(1):23-36. PubMed ID: 37160814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laminin 5 expression in metaplastic breast carcinomas.
    Carpenter PM; Wang-Rodriguez J; Chan OT; Wilczynski SP
    Am J Surg Pathol; 2008 Mar; 32(3):345-53. PubMed ID: 18300817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TERT Promoter Mutation c.-124C>T Commonly Occurs in Low-Grade Fibromatosis-like Metaplastic Breast Carcinoma.
    Webersinke G; Burghofer J; Malli T; Rammer M; Jahn SW; Niendorf A; Tavassoli FA; Moinfar F
    Arch Pathol Lab Med; 2023 Dec; 147(12):1451-1457. PubMed ID: 36897999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptomic alterations underlying metaplasia into specific metaplastic components in metaplastic breast carcinoma.
    Lien HC; Hsu CL; Lu YS; Chen TW; Chen IC; Li YC; Huang CS; Cheng AL; Lin CH
    Breast Cancer Res; 2023 Jan; 25(1):11. PubMed ID: 36707876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic profiling of malignant phyllodes tumors reveals aberrations in FGFR1 and PI-3 kinase/RAS signaling pathways and provides insights into intratumoral heterogeneity.
    Liu SY; Joseph NM; Ravindranathan A; Stohr BA; Greenland NY; Vohra P; Hosfield E; Yeh I; Talevich E; Onodera C; Van Ziffle JA; Grenert JP; Bastian BC; Chen YY; Krings G
    Mod Pathol; 2016 Sep; 29(9):1012-27. PubMed ID: 27255162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.